Parahexyl

Parahexyl is a synthetic cannabinoid that was developed in the 1960s. It is similar in structure to THC, the active ingredient in cannabis, but has a slightly altered chemical structure. Parahexyl is also known as Synhexyl.

History

Parahexyl was developed in the 1960s as part of a series of cannabinoid drugs, which also included HU-210, HU-211, HU-239, and others. These drugs were developed in an attempt to create a synthetic form of cannabis that could be used for medical purposes.

Pharmacology

Parahexyl is a synthetic cannabinoid, which means it mimics the effects of natural cannabinoids found in the cannabis plant. It binds to the CB1 receptor and CB2 receptor, which are found in the brain and immune system respectively. This binding action is what causes the drug's effects.

Effects

The effects of Parahexyl are similar to those of THC, but with a slightly longer duration of action. These effects can include relaxation, euphoria, altered perception, and in some cases, hallucinations. However, like all drugs, Parahexyl also has potential side effects, which can include dry mouth, red eyes, and in rare cases, paranoia or anxiety.

Legal status

Parahexyl is currently a Schedule I controlled substance in the United States, which means it is illegal to manufacture, distribute, or possess without a license from the Drug Enforcement Administration.

See also

• Cannabinoid
• Synthetic cannabinoids
• Cannabis (drug)

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

• 
  Parahexyl skeletal structure
• 
  Dibenzopyran and monoterpenoid numbering of tetrahydrocannabinol